Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Nanoviricides, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 34 | 28 | −6 |
| Shares | 992.2K | 909.5K | −82.7K (−8.3%) |
| Value | $4.68M | $4.22M | −$460.8K (−9.8%) |
New holders (2)
Institutions that held Nanoviricides, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 40,506 | $188.0K | 0.00% |
| Alaethes Wealth LLC | 2,133 | $10.0K | 0.01% |
Sold out (8)
Institutions that held Nanoviricides, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Citadel Advisors LLC | 30,342 | $143.0K |
| Blueshift Asset Management, LLC | 20,216 | $95.0K |
| Engineers Gate Manager LP | 13,600 | $64.0K |
| Commonwealth Equity Services, LLC | 10,498 | $49.0K |
| Simplex Trading, LLC | 4,869 | $22.0K |
| Bank of Montreal | 1,000 | $5.00K |
| Steward Partners Investment Advisory, LLC | 750 | $3.54K |
| Clearstead Advisors, LLC | 293 | $1.00K |